Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report.

Stefania Cerri, Giacomo Sgalla, Luca Richeldi, Fabrizio Luppi

Open access · goldAbstract readCase Reports

In one paragraph

Article in Journal of medical case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.5field-weighted citation impact, top 29% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Stefania CerriCenter for Rare Lung Diseases, University Hospital Policlinico di Modena, Via del Pozzo, 71-41124, Modena, Italy.

Giacomo SgallaNational Institute for Health Research Respiratory Biomedical Research Unit, Mailpoint 813, LE75 E Level, South Academic Block, Southampton, UK.

Luca RicheldiNational Institute for Health Research Respiratory Biomedical Research Unit, Mailpoint 813, LE75 E Level, South Academic Block, Southampton, UK.

Fabrizio LuppiCenter for Rare Lung Diseases, University Hospital Policlinico di Modena, Via del Pozzo, 71-41124, Modena, Italy. fabrizio.luppi@unimore.it.

Policlinico di Modena · ITUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmunosuppressive therapy has been-until the recent release of new guidelines on diagnosis and management-the recommended treatment for idiopathic pulmonary fibrosis. However, its efficacy in patients with idiopathic pulmonary fibrosis has always been a matter of debate. CASE PRESENTATION: We report the occurrence of idiopathic pulmonary fibrosis in a white man receiving chronic immunosuppressive treatment following a heart transplant.

conclusionsThis case report suggests that the immune mechanisms targeted by azathioprine and cyclosporine do not play a role in the pathogenesis of idiopathic pulmonary fibrosis.

Indexed as

Heart TransplantationAgedAzathioprineCyclosporineFatal OutcomeHumansIdiopathic Pulmonary FibrosisImmunosuppressive AgentsLungMaleRadiographyTomography, X-Ray ComputedAzathioprineCyclosporineImmunosuppressive AgentsHeart transplantationIdiopathic pulmonary fibrosisImmunosuppressantSteroidsTreatment

Identifiers

PMID27387033

DOI10.1186/s13256-016-0916-5

PMCPMC4937572

OpenAlexW2403512159

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.